Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments utilizing Dynamic Pressure Sensing™ (DPS) technology, today highlighted the continued ...

This appointment further supports Milestone Scientific’s strategy to drive adoption of its CompuFlo® Epidural System, broaden access under recently assigned favorable Medicare Part B payment rates for ...

Management guided 2026 total revenue to "$9.8 million to $10.2 million," which CEO Eric Hines said is "reflecting double-digit year-over-year growth, driven by expanding adoption across both markets." ...

Operating Loss Reduced As Company Advances Toward ProfitabilityReaffirms Outlook for Double-Digit Revenue Growth in 2026, including Significant ...

View Milestone Scientific Inc. MLSS stock quote prices, financial information, real-time forecasts, and company news from CNN.

Milestone Scientific (MLSS) announced that its CEO Arjan Haverhals will retire from his role as an officer of the company on December 31. Upon his retirement, Haverhals will continue to serve as a ...

Milestone Scientific offers an innovative product line in the medical and dental segments, including a trademarked solution for Dentists to administer local anesthesia called SingleTooth Anesthesia.

ROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE)-- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, ...

Milestone Scientific Inc ( (MLSS)) has released its Q3 earnings. Here is a breakdown of the information Milestone Scientific Inc presented to its investors. Milestone Scientific Inc., a Delaware-based ...

ROSELAND, N.J.--(BUSINESS WIRE)--With post epidural side effects becoming more serious than previously known, today Milestone Scientific Inc. announced the availability of its CompuFlo ® Epidural ...

Operator: Greetings, and welcome to the Milestone Scientific Third Quarter 2025 Financial Results and Business Update Call. [Operator Instructions] And please note, this conference is being recorded.